•Evaluación de la Remisión en Colitis Ulcerosa: Relación entre Marcadores ClÃnicos, Endoscópicos e Histológicos como Predictores de RecaÃda
•CGA protects against experimental colitis by modulating host purine metabolism through the gut microbiota
•Correction to: P0722 Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn's Disease: Results From the One-Year SEQUENCE Open-Label Long-Term Extension
•Stercoral Colitis: Review of Imaging Features and Complications
•Management of Atherosclerotic Cardiovascular Risk in Inflammatory Bowel Disease: Current Perspectives